Form 4 for SNDX Syndax Pharmaceuticals Inc
Accepted 2022-09-16 00:00:00 ET · period of report 2022-09-14 · accession 0001562180-22-006706 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-09-16 | 2022-09-14+ | SNDX | Morrison Briggs | Pres, Head of R, D, Dir | M - OptEx | $7.90 | +279.4K | 84.6K | New | +$2.21M |
| DM | 2022-09-16 | 2022-09-14+ | SNDX | Morrison Briggs | Pres, Head of R, D, Dir | S - Sale+OE | $23.64 | -279.4K | 17.8K | -94% | -$6.60M |
| DM | 2022-09-16 | 2022-09-14+ | SNDX | Morrison Briggs | Pres, Head of R, D, Dir | M - OptEx | $0.00 | -279.4K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-16 | M | A | 53,034 | $10.90 | 70,870 | D | — | — | |
| 2 | Common | Common Stock | 2022-09-16 | S | D | 53,034 | $23.22 | 17,836 | D | — | — | (F4) The sale prices ranged from $22.96 to $23.99 |
| 3 | Common | Common Stock | 2022-09-15 | S | D | 66,775 | $24.20 | 17,836 | D | — | — | (F3) The sale prices ranged from $23.36 to $24.64 |
| 4 | Common | Common Stock | 2022-09-14 | S | D | 87,645 | $23.80 | 17,836 | D | — | — | (F2) The sale prices ranged from $23.36 to $24.01 |
| 5 | Common | Common Stock | 2022-09-14 | M | A | 87,645 | $7.20 | 105,481 | D | — | — | |
| 6 | Common | Common Stock | 2022-09-16 | S | D | 71,966 | $23.22 | 17,836 | D | — | — | (F4) The sale prices ranged from $22.96 to $23.99 |
| 7 | Common | Common Stock | 2022-09-16 | M | A | 71,966 | $7.20 | 89,802 | D | — | — | |
| 8 | Common | Common Stock | 2022-09-15 | M | A | 66,775 | $7.20 | 84,611 | D | — | — | |
| 9 | Derivative | Stock Options (Right to buy) | 2022-09-14 | M | D | 87,645 | $0.00 | 0 | D | $7.20 · — to 2025-06-30 | 87,645 Common Stock | (F5) This option is fully vested. |
| 10 | Derivative | Stock Options (Right to buy) | 2022-09-15 | M | D | 66,775 | $0.00 | 0 | D | $7.20 · — to 2025-06-30 | 66,775 Common Stock | (F5) This option is fully vested. |
| 11 | Derivative | Stock Options (Right to buy) | 2022-09-16 | M | D | 71,966 | $0.00 | 0 | D | $7.20 · — to 2025-06-30 | 71,966 Common Stock | (F5) This option is fully vested. |
| 12 | Derivative | Stock Options (Right to buy) | 2022-09-16 | M | D | 53,034 | $0.00 | 0 | D | $10.90 · — to 2025-09-09 | 53,034 Common Stock | (F5) This option is fully vested. |